SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-087827
Filing Date
2020-07-29
Accepted
2020-07-29 16:57:26
Documents
14
Period of Report
2020-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025879d1_8k.htm   iXBRL 8-K 37297
2 EXHIBIT 99.1 tm2025879d1_ex99-1.htm EX-99.1 644111
  Complete submission text file 0001104659-20-087827.txt   948830

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abbv-20200729.xsd EX-101.SCH 4481
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20200729_def.xml EX-101.DEF 30228
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20200729_lab.xml EX-101.LAB 41943
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20200729_pre.xml EX-101.PRE 28431
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2025879d1_8k_htm.xml XML 9939
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 201057754
SIC: 2834 Pharmaceutical Preparations